Report: Pharmaceutical sales to grow 5.1% on average through 2020
LONDON — Worldwide prescription drug sales are expected to exceed the trillion dollar mark by 2020, according to Evaluate's "World Preview 2014, Outlook to 2020" report released Wednesday. Evaluate projects the pharma industry to grow, on average, 5.1% per year from 2013 to 2020.
Biologicals will make up 52% of the top 100 prescription and OTC drug sales in 2020, Evaluate reported. Oncology will set record high growth with an 11.2% compound annual growth rate to 2020. Novartis is expected to remain the top company by global drug sales in 2020, Evaluate reported. Teva Pharmaceuticals was the leading generic drug maker in 2013.
“This much improved growth outlook comes as welcome news after two years of actual sales stagnation,” stated Paul Hills, report author and Evaluate’s head of operations. “While the patent cliff is now but a distant memory, a new debate over drug pricing is stirring up controversy. This will only intensify as the industry continues to shift away from primary care and new technology waves offer innovative products that potentially take costs out of healthcare.”
The “World Preview 2014, Outlook to 2020” report, based on market intelligence and consensus forecasts from EvaluatePharma, can be downloaded at Evaluategroup.com/wp2014, the company stated.
Cardinal Health enhances cardiovascular tools available to retail pharmacy
DUBLIN, Ohio — Cardinal Health on Wednesday outlined a number of enhanced tools to make it easier for retail pharmacies to help their patients better manage their cardiovascular health and prevent heart disease.
“As payers place an increasing emphasis on improving their performance on Medicare’s Star Ratings System, they’ll increasingly look to retail pharmacies to deliver services that help patients better manage cardiovascular risks and improve their overall heart health,” stated Brad Tice, product leader for Cardinal Health’s Medication Therapy Management Solution. “We’re excited to introduce these enhanced services, which will make it easier than ever before for community pharmacists to deliver heart health services to patients and to market these valuable services to physicians, employers and payers.”
Retail pharmacies that utilize Cardinal Health’s Specialized Care Center focused on Heart Health already have access to training, patient education, marketing tools, product and merchandising recommendations that help position them as a local destination for cardiovascular health needs.
Now, pharmacies that utilize Cardinal Health’s Heart Health Specialized Care Center also have access to:
- My Digital Health Coach patient tracking and reporting tools;
- New resources to make it easier to screen patients for cardiovascular risks;
- New continuing education courses to enhance their knowledge about effective strategies for improving heart health;
- Discounts on non-prescription products that patients with cardiovascular conditions need, like home diagnostics and pain relief products, vitamins and specialty supplements;
- New print and electronic marketing tools to educate local physicians and employers about how community pharmacists can help patients prevent heart disease and improve heart health; and
- New print and electronic promotional materials to market their heart health services to patients.
CDC: Half of all seniors deal with incontinence
ATLANTA — Slightly more than half of all seniors who are not in an assisted living situation reported having issues with incontinence, according to a report released Wednesday by the Centers for Disease Control and Prevention. Of the 50.9% who reported incontinence, 43.8% reported a urinary leakage, and 17.3% reported an accidental bowel leakage. Among those who reported an incontinence episode, the majority reported urinary but not accidental bowel leakage, while 10.6% of noninstitutionalized persons reported both urinary and bowel leakage.
More than one-half of noninstitutionalized women and more than one-quarter of noninstitutionalized men aged 65 and over reported a urinary leakage, CDC added.
Restricting the definition of bladder incontinence to include only moderate, severe and very severe levels of incontinence reduced the percentage with bladder incontinence among noninstitutionalized men and women from 43.8% to 24%. When only severe and very severe levels were considered, the percentage with bladder incontinence was 8.1%.
Among non-Hispanic white women, the percentage with urinary leakage was 1.8 times higher compared with non-Hispanic black women (58.3% compared with 33.4%). Observed differences in urinary leakage rates among noninstitutionalized persons by age, poverty level, level of education or marital status were not statistically significant.
"Incontinence presents a significant financial burden to the individual and to society," the CDC stated in its report. "In the United States, the cost of bladder incontinence among adults in 2000 was estimated at $19.5 billion, with $14.2 billion incurred by community residents and $5.3 billion by institutional residents. A majority (50%–75%) of the costs are attributed to resources used for incontinence management or 'routine care’ such as absorbent pads, protection and laundry."
In older persons, incontinence is associated with multiple interacting factors, including chronic conditions such as diabetes and stroke, cognitive impairment, and mobility impairment. Bladder incontinence may be caused by conditions such as age-related changes in the lower urinary tract, urinary tract infection and conditions not directly related to the genitourinary system, such as diabetes, cancer, stroke, cognitive impairment and mobility impairment.